- Home
- AQST vs ITRG Comparison
AQST vs ITRG Comparison
Compare AQST & ITRG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | AQST | ITRG |
|---|---|---|
| Founded | 2004 | 1997 |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Precious Metals |
| Sector | Health Care | Basic Materials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 707.6M | 780.9M |
| IPO Year | 2018 | N/A |
Fundamental Metrics
Financial Performance| Metric | AQST | ITRG |
|---|---|---|
| Price | $2.95 | $3.68 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 6 | 2 |
| Target Price | ★ $8.83 | $5.25 |
| AVG Volume (30 Days) | ★ 6.4M | 2.5M |
| Earning Date | 03-04-2026 | 11-12-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ 0.08 |
| Revenue | $43,397,000.00 | ★ $219,125,000.00 |
| Revenue This Year | N/A | $965.93 |
| Revenue Next Year | $43.02 | $9.39 |
| P/E Ratio | ★ N/A | $52.12 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $2.12 | $1.01 |
| 52 Week High | $7.55 | $4.87 |
Technical Indicators
Market Signals| Indicator | AQST | ITRG |
|---|---|---|
| Relative Strength Index (RSI) | 23.93 | 39.16 |
| Support Level | $3.17 | $4.22 |
| Resistance Level | $3.55 | $4.69 |
| Average True Range (ATR) | 0.25 | 0.30 |
| MACD | -0.03 | -0.05 |
| Stochastic Oscillator | 2.06 | 4.80 |
Price Performance
Historical ComparisonAbout AQST Aquestive Therapeutics Inc.
Aquestive Therapeutics Inc is a specialty pharmaceutical company engaged in developing and commercializing differentiated products to meet medical needs. Its later-stage product pipeline focuses on the treatment of diseases of the Central Nervous System (CNS), and an earlier-stage pipeline for the treatment of severe allergic reactions, including anaphylaxis. Its commercial product portfolio includes Suboxone, Emylif, Ondif and Sympazan. The product pipeline includes Libervant Buccal Film, AQST-108. The majority of its revenue comes from the United States.
About ITRG Integra Resources Corp.
Integra Resources Corp is a precious metals exploration and development company in the Great Basin of the Western USA. Integra is currently focused on advancing its two flagship oxide heap leach projects: the past-producing DeLamar Project located in southwestern Idaho and the Nevada North Project, comprised of the Wildcat and Mountain View deposits, located in northwestern Nevada. The company also holds a portfolio of prospective early-stage exploration projects in Idaho, Nevada, and Arizona.